You searched for Humanized antibody - Page 24 of 44

News and Trends 9 Jun 2023

Astellas developing new gastric cancer drug

…antibody, for first-line treatment of patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma whose tumors are CLDN18.2-positive. If approved, zolbetuximab would be the first…

June 9, 2023 - 4 minutesmins - By Jim Cornall

In Depth 8 Oct 2024

Top biotech deals of September 2024

…bispecific antibody to its immunotherapy pipeline. The deal amount was undisclosed. Biotech deals by approach in September 2024 The business of RNA therapeutics Among all the major deals signed last month,…

October 8, 2024 - 6 minutesmins - By Roohi Mariam Peter

News and Trends 2 Jun 2025

Top biotech deals in May 2025

…further and potentially commercialize them. Besides, Taiwanese company Formosa Pharmaceuticals and Northern Ireland-based Almac Discovery have begun a collaboration over antibody-drug conjugates (ADCs). Formosa will gain control of Almac’s solid…

June 2, 2025 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 16 Dec 2022

Alchemab Therapeutics receives £1.7M grant to work on therapy for Huntington’s disease

…to accelerate development of our antibody and deliver some hope for patients.” This is the second grant awarded to Alchemab and MDC. The financing will support preclinical development of the…

December 16, 2022 - 3 minutesmins - By Jim Cornall

geneuro multiple sclerosis neuron viral dna

News and Trends 12 Mar 2019

Blocking Hidden Viral Protein Shows Promise for Treating Multiple Sclerosis

An antibody that blocks the action of a hidden viral protein encoded by our genome shows encouraging signs of slowing down the progression of multiple sclerosis, according to the Swiss…

March 12, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 15 Oct 2020

Swiss Biotech Launches Amidst Hot Streak for Rare Autoimmune Disease

…there were no approved treatments for neuromyelitis optica. That year, Alexion Pharmaceuticals’ Soliris, a monoclonal antibody targeting the complement protein C5, was approved for the treatment of this condition by…

October 15, 2020 - 3 minutesmins - By Helen Albert

pure biologics wroclaw devics disease 1 1

Startup Scout 31 May 2019

This Biotech Treats a Neurological Autoimmune Disorder Using DNA

…begin clinical trials in 2023. Pure Biologics also has a separate program developing an antibody drug that binds two targets at once, called a bispecific antibody. Although there are other…

May 31, 2019 - 4 minutesmins - By Jonathan Smith

News and Trends 28 Sep 2018

Roche Acquires UK Cancer Immunotherapy Biotech in Deal Worth up to €655M

…cells called regulatory T cells. These cells hold back the immune system from attacking tumors, thus the antibody helps the patient’s immune system to fight the cancer. The antibody has…

September 28, 2018 - 2 minutesmins - By Jonathan Smith

large molecule manufacturing: Lonza woman working in laboratory

Large molecule manufacturing: addressing challenges with strategies for success

…the characteristics of the molecule. This panel of offerings covers a broad range of protein modalities that include antibody-based products, such as bispecific antibodies, Fc-Fusion proteins, and antibody fragments, and…

March 26, 2024 - 8 minutesmins - By Alexander Burik

News and Trends 16 Feb 2023

Maxion Therapeutics raises $16M to target GPCRs

…co-founded CAT (acquired by AstraZeneca for £700 million) and IONTAS (acquired by FairJourney Biologics). At CAT, McCafferty co-invented antibody phage display, the technology used to discover the world’s best-selling drug,…

February 16, 2023 - 3 minutesmins - By Jim Cornall

Weekly Roundup 24 Nov 2023

Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA

…an antibody that was discovered based on WuXi Bio’s integrated technology platforms, so that Myricx can develop an ADC using the antibody, to target solid tumors, through its NMT-1 platform….

November 24, 2023 - 14 minutesmins - By Roohi Mariam Peter

Best in Biotech 10 Jun 2025

Pushing biotech forward in France: 18 companies to know about

…agonist for right heart failure and potentially other cardiometabolic diseases. COR-2007: An AVP-neutralizing monoclonal antibody aimed at treating acute heart failure with hyponatremia. DiogenX Founded: 2020 Headquarters: Marseille, France Focus:…

June 10, 2025 - 16 minutesmins - By Jules Adam

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

Astellas developing new gastric cancer drug

Top biotech deals of September 2024

Top biotech deals in May 2025

Alchemab Therapeutics receives £1.7M grant to work on therapy for Huntington’s disease

Blocking Hidden Viral Protein Shows Promise for Treating Multiple Sclerosis

Swiss Biotech Launches Amidst Hot Streak for Rare Autoimmune Disease

This Biotech Treats a Neurological Autoimmune Disorder Using DNA

Roche Acquires UK Cancer Immunotherapy Biotech in Deal Worth up to €655M

Large molecule manufacturing: addressing challenges with strategies for success

Maxion Therapeutics raises $16M to target GPCRs

Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA

Pushing biotech forward in France: 18 companies to know about

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!